Sökning: onr:"swepub:oai:DiVA.org:liu-72650" > Impact of tumour si...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03096naa a2200361 4500 | |
001 | oai:DiVA.org:liu-72650 | |
003 | SwePub | |
008 | 111202s2011 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-726502 URI |
024 | 7 | a https://doi.org/10.3109/00365599.2011.5909952 DOI |
040 | a (SwePub)liu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Jancke, Georgu Linköpings universitet,Hälsouniversitetet,Onkologi4 aut0 (Swepub:liu)geoja67 |
245 | 1 0 | a Impact of tumour size on recurrence and progression in Ta/T1 carcinoma of the urinary bladder |
264 | c 2011-06-16 | |
264 | 1 | b Informa Healthcare,c 2011 |
338 | a print2 rdacarrier | |
520 | a Objective. This study aimed to evaluate the impact of tumour size on recurrence and progression in a population-based series of non-muscle-invasive bladder cancers. Material and methods. Clinical and pathological characteristics of patients with primary Ta/bladder cancer were registered. The patients tumours were categorized by size into five size groups (1-10, 11-20, 21-30, 31-40 and andgt;40 mm) or three size groups (1-15, 16-30 and andgt;30 mm). Results. The analysis included 768 evaluable patients with a mean follow-up of 60 months. Recurrence was observed in 478 patients (62%) and progression in 71 (9%). Tumour size was associated with recurrence for tumours sized 21-30, 31-40 and andgt;40 mm (p = 0.03, p andlt; 0.001, p andlt; 0.001, respectively) in the five size group and for tumours sized 16-30 and andgt;30 mm (p = 0.003 and p andlt; 0.001) in the three size group. Other factors affecting recurrence were T1 tumour category, multiplicity and surgery performed by residents (p andlt; 0.001, p andlt; 0.001, p = 0.002, respectively). Considering progression, there was no significant association with tumour size, and T1 category and local recurrence were the only significant risk factors (both p andlt; 0.001). Conclusion. Tumour size andlt;= 15 mm is associated with a lower risk of recurrence but not progression. Dividing tumour size into three size groups gives additional information compared with two size groups with cut-off at 30 mm. | |
653 | a progression | |
653 | a recurrence | |
653 | a tumour size | |
653 | a urinary bladder cancer | |
653 | a MEDICINE | |
653 | a MEDICIN | |
700 | 1 | a Rosell, Johanu Östergötlands Läns Landsting,Linköpings universitet,Onkologi,Hälsouniversitetet,Onkologiska kliniken US4 aut0 (Swepub:liu)johro19 |
700 | 1 | a Jahnson, Staffanu Östergötlands Läns Landsting,Linköpings universitet,Kirurgi,Hälsouniversitetet,Urologiska kliniken i Östergötland4 aut0 (Swepub:liu)staja74 |
710 | 2 | a Linköpings universitetb Hälsouniversitetet4 org |
773 | 0 | t Scandinavian Journal of Urology and Nephrologyd : Informa Healthcareg 45:6, s. 388-392q 45:6<388-392x 0036-5599x 1651-2065 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-72650 |
856 | 4 8 | u https://doi.org/10.3109/00365599.2011.590995 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.